can semaglutide affect liver The FDA has granted accelerated approval for Wegovy (semaglutide 2.4 mg, once‑weekly) to treat metabolic dysfunction–associated steatohepatitis (MASH) in adults with moderate to advanced fibrosis (F2–F3) without cirrhosis. This is standout Ozempic and Wegovy ingredient may
Description
In stock UK

Learn differences, results, side effects, and how to choose the right GLP-1 option.

CMS announced the Medicare GLP-1 Bridge on December 23, 2025, as a temporary demonstration project to help beneficiaries obtain coverage.

Learn how semaglutide curbs appetite and supports weight loss
